Why did PANJON.BO stock spike in pre-market trading?

The pre-market spike to **INR 24.61** reflects heavy volume of **170,620** shares versus avg **14,086**, suggesting momentum buying. With no major public earnings surprise, the move is likely trader-driven and linked to liquidity and short-term positioning.

What are realistic price targets for PANJON.BO stock?

We outline a near-term target of **INR 25.50** and a tactical target of **INR 28.00**. Use a stop under **INR 20.50** to limit downside; adjust targets if liquidity or fundamentals change.

How does Meyka AI rate PANJON.BO stock and what does it mean?

Meyka AI rates PANJON.BO **61.34/100 (Grade B, HOLD)**. This considers benchmark and sector comparisons, financial metrics, growth and analyst inputs. It is informational and not investment advice.

What key risks should investors watch for PANJON.BO stock?

Main risks include thin liquidity, high trailing PE **58.60**, low net margin **1.61%**, and reliance on distributor or product updates. Price can move sharply on small order flows.

IN Stocks

PANJON.BO stock up 19.99% pre-market on 23 Jan 2026: watch volume

ByHuzaifa Zahoor January 23, 2026

PANJON.BO stock leads pre-market gainers after a 19.99% intraday rise to INR 24.61 on the BSE on 23 Jan 2026. Trading opened at INR 20.50 and the stock hit a pre-market high of INR 24.61 on a volume spike of 170,620 shares, well above the average volume of 14,086.00. This move makes Panjon Ltd. one of the top gainers in the Healthcare (Medical – Pharmaceuticals) group in India. We review fundamentals, technicals, the Meyka AI grade and model forecasts to explain the jump and outline near-term levels to watch.